Related news and insights
Recent news articles and thought leadership
The round was co-led by Vsquared Ventures and EastX Ventures, with participation from firstminute capital, UK Innovation & Science Seed Fund (UKI2S), Brevan Howard Macro Venture and Geometry.
StandardX, co-founded in 2025 by Richard Pearson and Ross Allen, is building the world’s first isotope refinery, an accelerator system capable of scaling supply of the full portfolio of isotopes wherever it is deployed. Isotopes underpin innovation across healthcare, energy and other critical sectors, but global production is constrained, reliant on a limited number of ageing facilities. StandardX is unlocking a scalable and reliable supply of isotopes, starting with isotopes for cancer medicine where shortages are most acute.
On working with Harbottle & Lewis, StandardX co-founder Richard Pearson said:
“Having Tony, Rosie, Kate and the whole Harbottle & Lewis team alongside us from the start of our journey has been invaluable. They have been a joy to work with, and have helped us navigate multiple fronts, and to move quickly with eyes open. We are excited to continue working together on the road ahead!”
Harbottle & Lewis has advised StandardX since its incorporation in 2025. The team was led by co-managing partner and co-head of the firm’s venture capital practice, Tony Littner and managing associate Rosie Marston, with support from associate Kate Merry.
Commenting on the transaction, Tony Littner said:
“Richard and Ross are exactly the types of entrepreneurs we love to back at Harbottle. They are building a platform to address a real world need. We feel proud and privileged to have been able to support them on their journey so far and are looking forward to the next chapter”.
Recent news articles and thought leadership